Breaking News Instant updates and real-time market news.

FB

Facebook

$193.23

10.59 (5.80%)

, INTC

Intel

$57.59

-1.13 (-1.92%)

07:35
04/26/19
04/26
07:35
04/26/19
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Thursday in Facebook (FB), Intel (INTC), Marvell (MRVL), Anadarko (APC), Occidental Petroleum (OXY), Zynga (ZNGA), Goodyear Tire (GT), Cara Therapeutics (CARA), and Republic Services (RSG).

FB

Facebook

$193.23

10.59 (5.80%)

INTC

Intel

$57.59

-1.13 (-1.92%)

MRVL

Marvell

$25.42

-0.03 (-0.12%)

APC

Anadarko

$71.76

0.35 (0.49%)

OXY

Occidental Petroleum

$61.81

-0.19 (-0.31%)

ZNGA

Zynga

$5.47

-0.115 (-2.06%)

GT

Goodyear Tire

$19.56

-0.54 (-2.69%)

CARA

Cara Therapeutics

$19.39

0.335 (1.76%)

RSG

Republic Services

$79.46

0.16 (0.20%)

  • 26

    Apr

  • 28

    Apr

  • 01

    May

  • 05

    May

  • 06

    May

  • 07

    May

  • 08

    May

  • 10

    May

  • 14

    May

  • 16

    May

  • 17

    May

  • 22

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

  • 05

    Jun

  • 25

    Jul

  • 13

    Nov

FB Facebook
$193.23

10.59 (5.80%)

04/25/19
04/25/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Facebook (FB) upgraded to Buy from Neutral at UBS with analyst Eric Sheridan saying while 2019 remains a year of transition, Facebook management has now produced multiple quarters of better than expected revenue and earnings. 2. American Express (AXP) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Betsy Graseck saying she believes its strong revenue growth remains intact given its record growth in proprietary cards, strong contribution from Millennials, fee-based products and its strong loan and transactional growth. 3. Novartis (NVS) upgraded to Buy from Neutral at Guggenheim with analyst Seamus Fernandez saying he is more confident that the company "can deliver several years of mid-single digit operating profit and EPS growth" through 2024. 4. Sirius XM (SIRI) upgraded to Buy from Hold at Pivotal Research with analyst Jeffrey Wlodarczak saying yesterday's post-earnings selloff was overdone as investors overreacted to slightly lower than expected new car installations and modestly lower than expected self-pay net subscriber additions. 5. General Dynamics (GD) upgraded to Neutral from Underweight at JPMorgan with analyst Seth Seifman saying General Dynamics has underperformed the market by~21% since the start of 2018. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/25/19
RBCM
04/25/19
NO CHANGE
Target $250
RBCM
Outperform
Facebook price target raised to $250 from $200 at RBC Capital
RBC Capital analyst Mark Mahaney raised his price target on Facebook to $250 and kept his Outperform rating after its Q1 revenue and operating income topped expectations on the strength of its Instagram performance and the pricing power of its advertising platform. The analyst notes that the quarter has made him "more positive" at the margin with the company's worst fears "not realized" and adding that the stock may be in a period of a "sustained re-rating."
04/25/19
COWN
04/25/19
NO CHANGE
Target $225
COWN
Outperform
Facebook price target raised to $225 from $195 at Cowen
Cowen analyst John Blackledge raised his price target for Facebook to $225 from $195 after the company reported "strong" Q1 results. The analyst reiterates an Outperform rating on the shares.
04/25/19
BMOC
04/25/19
NO CHANGE
Target $200
BMOC
Market Perform
Facebook price target raised to $200 from $190 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Facebook to $200 and also raised his FY19 EPS view to $7.76 from $7.41 after its better than expected Q1 results, noting that the management reduced its outlook for operating expense in 2019. The analyst is keeping his Market Perform rating on Facebook shares however, forecasting the company's revenue deceleration to bottom in Q4 of this year before an upward inflection in Q1 on ramping Stories demand. Salmon adds that despite the "regulatory overhang", he remains on the "positive side" of his rating as the stock price has reflected his "more cautious view on margins".
INTC Intel
$57.59

-1.13 (-1.92%)

04/17/19
BARD
04/17/19
NO CHANGE
Target $10
BARD
Outperform
Lattice competitive landscape unchanged by Intel deal, says Baird
Shares of Lattice Semiconductor are trading lower on potential concerns related to smartphone procurement dynamics and the competitive landscape, Baird analyst Tristan Gerra tells investors in a research note. The analyst notes, however, that Lattice is de-emphasizing the smartphone market and no longer has content in Apple's (AAPL) new iPhones. Further, Intel's (INTC) acquisition of Omnitek does not change Lattice's competitive landscape, says Gerra. The analyst has an Outperform rating on Lattice Semiconductor with a $10 price target. The stock in afternoon trading is down 5%, or 62c, to $12.43.
04/18/19
ARGS
04/18/19
NO CHANGE
Target $225
ARGS
Buy
Apple to benefit from Qualcomm litigation settlement, says Argus
Argus analyst Jim Kelleher kept his Buy rating and $225 price target on Apple (AAPL), saying the company's "comprehensive legal settlement and new supply agreement with Qualcomm (QCOM)" should benefit the shares. The analyst notes that the decision to settle was driven by the realization that Apple may miss out on the 5G phone cycle upgrade, and the announcement by Intel (INTC) within hours of the settlement highlighted that the Street was more optimistic about its development of a viable 5G chip. Kelleher adds that the cost burden for Qualcomm chip and licensing is not "too severe", which he estimates to be below $25 on devices that may retail for over $1.1K. The analyst also notes that Apple stock remains "attractive compared to its historical valuations and to peer average multiples."
04/26/19
JPMS
04/26/19
NO CHANGE
Target $64
JPMS
Overweight
Intel selloff on guidance reset a buying opportunity, says JPMorgan
JPMorgan analyst Harlan Sur says that while Intel's revised outlook for 2019 is disappointing, the estimate cut of 5% is in-line with his preview where he had expected management to put forth conservative guidance with another round of earnings revisions. The analyst keeps an Overweight rating on Intel and would be a buyer of the stock on today's weakness. The company is achieving "better visibility supportive of strong cloud data center demand in the back half of the year," Sur tells investors in a research note.
04/26/19
RHCO
04/26/19
NO CHANGE
Target $56
RHCO
Hold
Intel price target raised to $56 from $53 at SunTrust
SunTrust analyst William Stein raised his price target on Intel (INTC) to $56 in spite of the weak March quarter and expected deterioration in the June quarter, saying the "modest" re-set of 2019 guidance implies a snap-back rebound in performance in the back half of the year. The analyst is keeping his Hold rating on Intel however, adding that the immediate weakness in the Data Center Group could be a negative for suppliers like Nvidia (NVDA). Stein also notes that he prefers his Buy-rated Broadcom (AVGO) because of its lower valuation, higher growth, and higher dividend yield.
MRVL Marvell
$25.42

-0.03 (-0.12%)

03/29/19
MZHO
03/29/19
NO CHANGE
Target $140
MZHO
Buy
Xilinx price target raised to $140 from $107 at Mizuho
Mizuho analyst Vijay Rakesh raised his price target for Xilinx (XLNX) to $140 from $107 following his trip to Asia and channel checks with the supply chain. Xilinx is a "significant leader" in 5G, with orders potentially up 50%-plus year-over-year in 2019 as the company is getting ~95% of 5G orders, Rakesh tells investors in a research note. The analyst also believes Xilinx has a "strong lead" over Intel (INTC) and Marvell Technology (MRVL). He reiterates a Buy rating on the shares.
04/24/19
UBSW
04/24/19
NO CHANGE
Target $29
UBSW
Buy
Marvell price target raised to $29 from $22 at UBS
UBS analyst Timothy Arcuri raised his price target on Marvell to $29 and kept his Buy rating, citing its position on the infrastructure side as 5G becomes a "more palpable investor theme." The analyst further notes that the buildout remains in its "very early innings", estimating about $1B in incremental revenue from 5G technology starting in 2020 and extending through 2023-24.
04/17/19
SBSH
04/17/19
NO CHANGE
Target $28
SBSH
Buy
Marvell price target raised to $28 from $22 at Citi
Citi analyst Atif Malik raised his price target for Marvell Technology Group to $28 from $22 citing improving storage fundamentals, increasing confidence in 5G momentum, and the company's "growing M&A appeal." Marvell is the best way of playing the "second wave" of 5G cycle spend as carriers' start to move to ASIC late this year, Malik tells investors in a research note. He keeps a Buy rating on the shares.
03/08/19
CHLM
03/08/19
NO CHANGE
Target $19
CHLM
Hold
Marvell shares fully valued at current levels, says Craig-Hallum
Craig-Hallum analyst Christian Schwab maintained a Hold rating and $19 price target on Marvell following the company's Q4 results, telling investors in a research note that FY20 is set to be a challenging year, albeit with an expected bottom in Q1 and improvement through the course of the year. Schwab does believe the company is well positioned with growth prospects in both 5G and automotive, but believes shares remain fully valued at current levels until he sees more tangible traction of the company's growth prospects.
APC Anadarko
$71.76

0.35 (0.49%)

04/25/19
JRCO
04/25/19
DOWNGRADE
JRCO
Hold
Anadarko downgraded to Hold from Buy at Johnson Rice
04/25/19
JEFF
04/25/19
DOWNGRADE
Target $79
JEFF
Hold
Jefferies downgrades Anadarko to Hold, sees limited upside from here
Jefferies analyst Mark Lear downgraded Anadarko Petroleum (APC) to Hold from Buy with an unchanged price target of $78. Occidental Petroleum (OXY) yesterday confirmed weeks of speculation that a superior bid for Anadarko had been disregarded in favor of Chevron's (CVX) $65 per share offer, Lear tells investors in a research note. The analyst says that while he awaits Anadarko's response to the hostile bid, he believes Occidental's offer better recognizes the value of the company's underlying assets. Lear thinks it is possible that Chevron could come back with a slightly higher bid. However, he sees limited upside potential to Anadarko shares at this point.
04/25/19
MSCO
04/25/19
NO CHANGE
MSCO
Strategic value of Occidental bid less clear than Chevron's, says Morgan Stanley
Morgan Stanley analyst Devin McDermott estimated that Occidental's (OXY) cash and stock bid for Anadarko (APC) implies about $73 per share, net of the breakup fee and yesterday's move in the share price of Occidental, which is roughly a 16% premium to Chevron's (CVX) previously accepted offer. However, Occidental's proposal comes with higher risk as it relies on asset sales for funding, requires a vote by Occidental's shareholders and carries more integration risk, the analyst tells investors. He continues to believe that a deal with Chevron represents a better potential strategic combination, citing his view that Chevron would ultimately be able to extract more synergies from a transaction than Occidental. If Chevron hypothetically matched Occidental's terms, the deal accretion would still be strong and leverage would stay low, said McDermott, who noted that he has no knowledge of any intention by Chevron to increase its bid.
04/25/19
SCOT
04/25/19
DOWNGRADE
SCOT
Sector Perform
Anadarko downgraded to Sector Perform from Outperform at Scotiabank
OXY Occidental Petroleum
$61.81

-0.19 (-0.31%)

04/24/19
JPMS
04/24/19
NO CHANGE
Target $74
JPMS
Neutral
Occidental's raised offer for Anadarko 'not entirely surprising,' says JPMorgan
Occidental Petroleum (OXY) made a $76 per share offer this morning for Anadarko (APC), which is "not entirely surprising," JPMorgan analyst Phil Gresh tells investors in a research note, adding that the new tidbits were the magnitude of synergies that Occidental proposed, which was materially higher than Chevron's (CVX), and Occidental's corresponding asset sale plan of $10B-15B. Gresh believes the merits of this transaction hinge entirely on the execution of the large synergy number being proposed, but also says he would not be surprised if Chevron raised its $65 per share bid for Anadarko and correspondingly raised its synergy target. The analyst maintains a Neutral rating and $74 price target on Occidental Petroleum.
04/25/19
ATLE
04/25/19
DOWNGRADE
ATLE
Neutral
Occidental Petroleum downgraded to Neutral from Overweight at Atlantic Equities
ZNGA Zynga
$5.47

-0.115 (-2.06%)

03/12/19
MSCO
03/12/19
NO CHANGE
Target $5.75
MSCO
Overweight
Zynga quarter-to-date bookings encouraging, says Morgan Stanley
Morgan Stanley analyst Brian Nowak said he thinks quarter-to-date trends for Zynga's portfolio imply modest organic growth in Q1 against record bookings last quarter, adding that he believes "Merge Dragons" is performing particularly well. After raising his 2019 and 2020 EBITDA estimates by 5% and 4%, respectively, driven by increased near-term expectations for "Merge Dragons" and "Empires & Puzzles," Nowak increased his price target on Zynga shares to $5.75 from $5.25 and keeps an Overweight rating on the stock.
04/22/19
PIPR
04/22/19
NO CHANGE
PIPR
Activision, Zynga Q1 mobile revenue have upside potential, says Piper Jaffray
Piper Jaffray analyst Michael Olson says his firm's Q1 "mobile meter" analysis of iOS app rankings suggests Q1 mobile revenue for Activision Blizzard (ATVI) and Zynga (ZNGA) has upside potential, with Glu Mobile (GLUU) likely in-line and Electronic Arts (EA) tracking slightly below. For Activision and Zynga, titles in the top 100 and average rank both improved quarter, Olson tells investors in a research note. For Activision, the analyst is modeling a 1% quarter-over-quarter decline in King revenue, while for Zynga, he's modeling a 26% increase in mobile. Glu Mobile rankings worsened quarter-over-quarter, as expected, due to seasonal decline in Tap Sports Baseball, says the analyst. However, he notes this appears in-line with his estimate for down 7% quarter-over-quarter in-app transaction revenue. EA mobile data was down quarter-over-quarter, Olson notes, but he estimates a 2% increase in mobile revenue, "so this is slightly below plan." The analyst keeps Overweight ratings on Activision, EA, Glu Mobile, Take-Two (TTWO) and Zynga.
03/26/19
MSCO
03/26/19
NO CHANGE
MSCO
Apple Arcade doesn't pose major threat to game makers, says Morgan Stanley
After Apple (AAPL) announced Arcade, a subscription service for mobile games, Morgan Stanley Brian Nowak said the service does not currently pose a major competitive threat to large game publishers Activision Blizzard (ATVI), Electronic Arts (EA) or Take-Two (TTWO). Apple's service doesn't include AAA quality content substitutable for their key franchises and didn't disclose plans to create its own first-party content, noted Nowak, who said that Apple could potentially be a direct competitor to mobile-focused Zynga (ZNGA). However, the overlap is limited by the fact that Zynga focuses exclusively on free-to-play, Nowak added.
02/07/19
PIPR
02/07/19
NO CHANGE
Target $6
PIPR
Overweight
Zynga price target raised to $6 from $5 at Piper Jaffray
Piper Jaffray analyst Michael Olson raised his price target for Zynga to $6 after the company reported Q4 bookings and adjusted EBITDA above consensus. Further, the company's Q1 bookings and adjusted EBITDA guidance also came in ahead of expectations, Olson tells investors in a post-earnings research note. The analyst believes Zynga's pipeline for 2019 may include a new Harry Potter title, Game of Thrones title, new expansion of the Merge! franchise, and either Farmville or Cityville mobile. He maintains an Overweight rating on the shares.
GT Goodyear Tire
$19.56

-0.54 (-2.69%)

02/11/19
02/11/19
DOWNGRADE

Hold
Goodyear Tire downgraded to Hold at Argus on higher input costs
As previously reported, Argus analyst David Coleman downgraded Goodyear Tire to Hold from Buy after its recent Q4 earnings miss, saying the observed impact of rising raw material costs is likely to persist in 2019. The analyst notes that while the stock price has fallen 4.5% over the past 3 months and trades at at below-peer-average multiples on earnings, the discount is warranted by its challenging near-term outlook. Coleman also lowers his FY19 EPS view on Goodyear Tire to $2.69 from $3.50, even though he is "more optimistic" about the company's long term potential.
02/11/19
02/11/19
DOWNGRADE
Target $14

Underperform
Goodyear Tire downgraded to Underperform on oversupply concerns at Longbow
As previously reported, Longbow analyst Anthony Deem downgraded Goodyear Tire to Underperform from Neutral as he believes a supply/demand imbalance in the Americas will continue to limit Goodyear's pricing power over the next several years. Goodyear's earnings growth is highly predicated upon an improving price/mix versus raw materials headwinds, but he sees that potential being capped by supply constraint issues and weak industry pricing power, Deem tells investors. He set a $14 price target on Goodyear Tire shares.
02/11/19
02/11/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Bed Bath & Beyond (BBBY) downgraded to Sell from Hold at Loop Capital with analyst Anthony Chukumba saying the recent rally in the shares as unwarranted as management's "much better-than-expected" fiscal 2019 financial guidance is "unrealistic." 2. Nvidia (NVDA) downgraded to Market Perform from Outperform at Bernsteinb with analyst Stacy Rasgon citing the company's "somewhat chilly guidance cut," which appears much more fundamentally demand-driven, with the question of the "true" run-rate of the gaming business remaining up in the air for now. 3. Aramark (ARMK) downgraded to Neutral from Conviction Buy at Goldman Sachs with analyst Stephen Grambling citing the miss in fiscal Q1, "increased fundamental volatility" embedded in guidance, and greater underlying labor pressures. 4. Goodyear Tire (GT) was downgraded to Underperform from Neutral at Longbow and to Hold from Buy at Argus. 5. Allete (ALE) downgraded to Underperform from Neutral at Mizuho with analyst Paul Fremont lowering his price target for the shares to $72 from $74 citing "additional execution pressure on its remaining business segments following its decision to sell the U.S. Water Services business." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/11/19
ARGS
02/11/19
DOWNGRADE
ARGS
Hold
Goodyear Tire downgraded to Hold from Buy at Argus
CARA Cara Therapeutics
$19.39

0.335 (1.76%)

01/02/19
PIPR
01/02/19
NO CHANGE
PIPR
Piper calls Horizon top 2019 growth idea in Specialty Pharmaceuticals
Piper Jaffray analyst David Amsellem calls Horizon Pharma (HZNP) his top "growth oriented/GARP idea" for 2019. The company offers high asset quality, visibility into significant longer-term EBITDA growth, and manageable debt levels that enable significant business development flexibility, Amsellem tells investors in a research note. He believes the Specialty Pharmaceuticals group is well positioned to perform more in-line with the broader therapeutics and overall healthcare spaces in 2019, or "certainly better than what we have seen in recent years." The analyst names Bausch Health (BHC), a stock he upgraded this morning to Overweight, his top "de-leveraging/defensive pick" for 2019. Further, Amsellem's top "development-stage picks" for 2019 are Cara Therapeutics (CARA) and Revance Therapeutics (RVNC).
01/15/19
BOFA
01/15/19
INITIATION
Target $19
BOFA
Neutral
Cara Therapeutics initiated with a Neutral at BofA/Merrill
BofA/Merrill analyst Jason Gerberry initiated Cara Therapeutics with a Neutral and $19 price target saying shares reflect maximum probability for lead asset IV Korsuva in Phase 3 for pruritus.
02/06/19
JEFF
02/06/19
INITIATION
Target $22
JEFF
Buy
Cara Therapeutics assumed with a Buy at Jefferies
Jefferies analyst Chris Howerton assumed coverage of Cara Therapeutics with a Buy rating and $22 price target. The analyst is optimistic on Korsuva, the company's "peripherally restricted, highly selective, and potent" kappa opioid receptor agonist that is being developed for pruritic indications.
04/08/19
STFL
04/08/19
NO CHANGE
Target $26
STFL
Buy
Cara could rise 'well past the mid-$20s' on good KALM-1 data, says Stifel
Stifel analyst Annabel Samimy noted that Cara Therapeutics should be reporting its first pivotal readout of Phase 3 KALM-1 data for CKD-associated pruritus in the hemodialysis population within weeks and she believes the share "could move well past the mid-$20s" on a positive outcome. The analyst, who applies a 75% probability of success to Korsuva in CKD-associated pruritus, keeps a Buy rating and $26 price target on Cara shares and would be a buyer ahead of the data.
RSG Republic Services
$79.46

0.16 (0.20%)

02/04/19
KEYB
02/04/19
INITIATION
KEYB
Sector Weight
Republic Services initiated with a Sector Weight at KeyBanc
KeyBanc analyst Sean Eastman initiated Republic Services with a Sector Weight rating. Eastman believes Republic Services is a high-quality bellwether, but the analyst said he would await a "clear catalyst to get constructive at current trading levels."
04/11/19
STFL
04/11/19
DOWNGRADE
Target $86
STFL
Hold
Republic Services downgraded to Hold from Buy at Stifel
Stifel analyst Michael Hoffman downgraded Republic Services to Hold from Buy with an unchanged price target of $86. While solid waste fundamentals are good, lower commodity prices represent a headwind for Republic Services, Hoffman tells investors in a research note. The latest groups tracking paper and paper production supply and demand have other corrugated cardboard in an oversupply position with limited visibility on that correcting soon, adds the analyst. He believes the company's Q1 "was noisy" and that recycling and weather "add more pressure."
04/04/19
UBSW
04/04/19
DOWNGRADE
Target $106
UBSW
Neutral
Waste Management downgraded to Neutral from Buy at UBS
UBS analyst Jon Windham downgraded Waste Management (WM) to Neutral from Buy while raising his price target for the shares to $106 from $103. The analyst sees a more balanced risk/reward profile following the stock's 17% year-to-date appreciation compared to the 11% return for peer Republic Services (RSG). Waste Management is now trading at a 30 basis point free cash flow yield discount to Republic Services compared to 50 basis point average free cash yield discount in January and 70 basis point average three-year discount, Windham tells investors in a research note.
04/01/19
STFL
04/01/19
NO CHANGE
Target $86
STFL
Buy
Republic Services on track for FY19 goals despite some Q1 pressure, says Stifel
Stifel analyst Michael Hoffman said the confidence of Republic Service's management team in the durability and quality of solid waste and its own position came through consistently in his recent meetings. He said the company intends to reaffirm guidance on the Q1 earnings call despite incremental pressure in Q1 from wet weather and weaker recycled prices. Following the meetings, he raised his price target on Republic Service shares to $86 from $84 and keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

PINS

Pinterest

$26.69

0.68 (2.61%)

08:37
05/18/19
05/18
08:37
05/18/19
08:37
Periodicals
Pinterest committed 'cardinal sin' for newly public company, Barron's says »

Pinterest released its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSHB

KushCo Holdings

$0.00

(0.00%)

08:32
05/18/19
05/18
08:32
05/18/19
08:32
Periodicals
Pot paraphernalia companies taking hit from tariffs, Barron's says »

The U.S.-China trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

JWN

Nordstrom

$37.09

0.16 (0.43%)

08:24
05/18/19
05/18
08:24
05/18/19
08:24
Periodicals
Nordstrom stock a 'can't miss bargain.' Barron's says »

Nordstrom remains the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 23

    May

NTDOY

Nintendo

$0.00

(0.00%)

, TTWO

Take-Two

$106.76

-0.81 (-0.75%)

08:10
05/18/19
05/18
08:10
05/18/19
08:10
Periodicals
Take-Two 'winning the game,' Barron's says »

Videogame stocks are down…

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$106.76

-0.81 (-0.75%)

DIS

Disney

$135.04

-0.46 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 24

    Jun

  • 13

    Nov

TPR

Tapestry

$30.78

-0.56 (-1.79%)

, REGN

Regeneron

$304.81

-4.69 (-1.52%)

08:01
05/18/19
05/18
08:01
05/18/19
08:01
Periodicals
Regeneron, Tapestry among cheap stocks to ride out trade war, Barron's says »

Applied Materials (AMAT),…

TPR

Tapestry

$30.78

-0.56 (-1.79%)

REGN

Regeneron

$304.81

-4.69 (-1.52%)

SCHW

Charles Schwab

$43.21

-0.94 (-2.13%)

BWA

BorgWarner

$36.27

-0.375 (-1.02%)

AMAT

Applied Materials

$42.72

-1.56 (-3.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 29

    May

  • 31

    May

  • 06

    Jun

  • 14

    Jun

  • 26

    Jun

  • 25

    Jul

MT

ArcelorMittal

$16.37

-0.485 (-2.88%)

, CLF

Cleveland-Cliffs

$10.02

-0.08 (-0.79%)

07:25
05/18/19
05/18
07:25
05/18/19
07:25
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

MT

ArcelorMittal

$16.37

-0.485 (-2.88%)

CLF

Cleveland-Cliffs

$10.02

-0.08 (-0.79%)

SCHN

Schnitzer Steel

$23.16

0.42 (1.85%)

BRSS

Global Brass and Copper

$43.09

-0.01 (-0.02%)

LXFR

Luxfer

$25.41

-0.44 (-1.70%)

MTRN

Materion

$66.36

0.155 (0.23%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$14.84

-0.01 (-0.07%)

F

Ford

$10.29

-0.1 (-0.96%)

GM

General Motors

$37.00

-0.36 (-0.96%)

HMC

Honda

$25.64

-0.135 (-0.52%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$118.40

-1.44 (-1.20%)

VWAGY

Volkswagen

$0.00

(0.00%)

SHOO

Steven Madden

$31.49

-0.37 (-1.16%)

GIII

G-III Apparel

$31.82

-0.35 (-1.09%)

IIVI

II-VI

$32.66

-1.64 (-4.78%)

LITE

Lumentum

$46.30

-4.15 (-8.23%)

MU

Micron

$36.06

-1.37 (-3.66%)

WDC

Western Digital

$44.62

-0.82 (-1.80%)

COHR

Coherent

$121.28

-5.22 (-4.13%)

LASR

nLight

$21.21

-1.27 (-5.65%)

VECO

Veeco

$12.50

-0.25 (-1.96%)

NPTN

NeoPhotonics

$3.83

-0.7 (-15.45%)

AAPL

Apple

$188.97

-0.93 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 24

    May

  • 28

    May

  • 29

    May

  • 03

    Jun

  • 04

    Jun

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 07

    Jun

  • 10

    Jun

  • 13

    Jun

  • 14

    Jun

  • 09

    Jul

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

  • 23

    Oct

WMT

Walmart

$100.88

-0.56 (-0.55%)

17:59
05/17/19
05/17
17:59
05/17/19
17:59
Hot Stocks
Walmart EVP Furner sells 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

  • 05

    Jun

  • 07

    Jun

  • 07

    Jun

  • 15

    Aug

  • 13

    Nov

XOM

Exxon Mobil

$75.91

-0.44 (-0.58%)

, REPYY

Repsol

$0.00

(0.00%)

17:56
05/17/19
05/17
17:56
05/17/19
17:56
Periodicals
Exxon Gulf of Mexico sale gets interest from Repsol, Ineos, Bloomberg says »

Exxon Mobil (XOM) has…

XOM

Exxon Mobil

$75.91

-0.44 (-0.58%)

REPYY

Repsol

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 29

    May

IEF

iShares 7-10 Year Treasury Bond ETF

$106.74

0.04 (0.04%)

, SHY

iShares 1-3 Year Treasury Bond

$84.15

0.02 (0.02%)

17:43
05/17/19
05/17
17:43
05/17/19
17:43
General news
Weekly CFTC Commitment of Traders highlights »

2-YEAR U.S. TREASURY net…

IEF

iShares 7-10 Year Treasury Bond ETF

$106.74

0.04 (0.04%)

SHY

iShares 1-3 Year Treasury Bond

$84.15

0.02 (0.02%)

SPY

SPDR S&P 500 ETF Trust

$285.98

-1.87 (-0.65%)

SLV

iShares Silver Trust

$13.52

-0.14 (-1.02%)

GLD

SPDR Gold Shares

$120.64

-0.86 (-0.71%)

FXE

Euro Currency Trust

$106.35

-0.13 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$285.98

-1.87 (-0.65%)

17:39
05/17/19
05/17
17:39
05/17/19
17:39
Periodicals
IMF's Lagarde: U.S.-China trade spat may be risk to global economy, Reuters says »

IMF managing director…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$285.98

-1.87 (-0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIG

Hartford Financial

$53.58

-0.02 (-0.04%)

17:34
05/17/19
05/17
17:34
05/17/19
17:34
Syndicate
Breaking Syndicate news story on Hartford Financial »

Hartford Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

AFH

Atlas Financial

$0.91

0.0225 (2.53%)

17:33
05/17/19
05/17
17:33
05/17/19
17:33
Hot Stocks
Atlas Financial receives filing delinquency notice from Nasdaq »

Atlas Financial received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WES

Western Gas Partners

$30.60

-0.155 (-0.50%)

17:29
05/17/19
05/17
17:29
05/17/19
17:29
Syndicate
Breaking Syndicate news story on Western Gas Partners »

Western Gas Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$354.99

0.5 (0.14%)

17:24
05/17/19
05/17
17:24
05/17/19
17:24
Hot Stocks
Boeing awarded $163.91M Navy contract modification »

Boeing has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

LMT

Lockheed Martin

$338.10

-2.39 (-0.70%)

17:18
05/17/19
05/17
17:18
05/17/19
17:18
Hot Stocks
Lockheed Martin subsidiary awarded $1.13B Navy contract modification »

Sikorsky, a Lockheed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

COTY

Coty

$13.50

0.25 (1.89%)

17:14
05/17/19
05/17
17:14
05/17/19
17:14
Hot Stocks
Coty exec Pieraccioni acquires 93,100 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMR

Alta Mesa Resources

$0.18

-0.0027 (-1.50%)

17:14
05/17/19
05/17
17:14
05/17/19
17:14
Hot Stocks
Alta Mesa Resources receives noncompliance notification from Nasdaq »

Nasdaq notified Alta Mesa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NJR

New Jersey Resources

$49.82

-0.03 (-0.06%)

17:06
05/17/19
05/17
17:06
05/17/19
17:06
Hot Stocks
New Jersey Resources' Trice sells 12,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

AHC

A.H. Belo

$3.82

-0.075 (-1.93%)

17:03
05/17/19
05/17
17:03
05/17/19
17:03
Hot Stocks
A.H. Belo sells former Dallas Morning News campus for $31.6M »

A. H. Belo announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRA

Telaria

$8.56

0.2 (2.39%)

17:01
05/17/19
05/17
17:01
05/17/19
17:01
Hot Stocks
Telaria director Rossman sells 173K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 10

    Jun

HL

Hecla Mining

$1.53

0.015 (0.99%)

16:58
05/17/19
05/17
16:58
05/17/19
16:58
Syndicate
Breaking Syndicate news story on Hecla Mining »

Hecla Mining files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INNT

Innovate Biopharmaceuticals

$1.59

-0.095 (-5.65%)

16:57
05/17/19
05/17
16:57
05/17/19
16:57
Syndicate
Breaking Syndicate news story on Innovate Biopharmaceuticals »

Innovate files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 31

    May

JONE

Jones Energy

$0.00

(0.00%)

16:56
05/17/19
05/17
16:56
05/17/19
16:56
Hot Stocks
Jones Energy emerges from bankruptcy »

Jones Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPP

Hudson Pacific

$34.33

-0.15 (-0.44%)

16:44
05/17/19
05/17
16:44
05/17/19
16:44
Hot Stocks
Hudson Pacific CFO sells ~57K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

GLYC

GlycoMimetics

$12.42

-0.43 (-3.35%)

16:36
05/17/19
05/17
16:36
05/17/19
16:36
Syndicate
Breaking Syndicate news story on GlycoMimetics »

GlycoMimetics files $250M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.